Cannabis Research Act
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Cannabis Research Act (H.R. 8901) was a bill introduced in the 118th Congress aimed at addressing issues related to cannabis research. The bill was referred to the House Committees on Energy and Commerce and the Judiciary for consideration of relevant provisions. However, the bill ultimately failed or expired without further legislative action. There is no official summary or full text available to provide detailed information on the bill's specific provisions or objectives. The policy area is identified as Health, suggesting a focus on medical or scientific research related to cannabis.
H.R. 8901, the Cannabis Research Act, sought to advance cannabis research but did not progress beyond committee referral and ultimately failed or expired in the 118th Congress.
- The bill was referred to the House Committees on Energy and Commerce and Judiciary for jurisdictional review.
- No official summary or full text is available, limiting detailed analysis of the bill's content.
- The bill is categorized under the Health policy area, indicating a focus on cannabis-related health research.
['Researchers and scientific institutions focused on cannabis studies', 'Health agencies involved in medical research', 'Potentially patients and medical professionals interested in cannabis-based treatments']
['Lack of available full text and summary limits understanding of implementation and oversight mechanisms', 'Unclear funding sources or budgetary impact due to missing detailed provisions', 'Potential jurisdictional overlap between committees could complicate legislative progress']
The bill was introduced in the House during the 118th Congress and referred to relevant committees for consideration. It did not advance beyond committee referral and was ultimately classified as failed or expired. The absence of detailed legislative text or summary suggests limited legislative momentum or prioritization within the congressional session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["Potential increased interest in cannabis research may persist despite the bill's failure, influencing future legislative efforts.", 'The referral to multiple committees could highlight jurisdictional complexities that might affect future cannabis-related legislation.', "The bill's failure may delay formal federal support or coordination for cannabis research initiatives."]
The absence of an official summary and full bill text limits transparency and public understanding of the Cannabis Research Act's specific provisions and intended impact. The bill's failure to advance beyond committee referral underscores the importance of tracking legislative progress and committee actions to assess policy development. Future transparency efforts should ensure that bill texts and summaries are made publicly available to facilitate informed analysis and oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.